Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
crispr-cas9
2
×
detroit blog main
detroit top stories
eli lilly
fda
glaxosmithkline
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vertex pharmaceuticals
wisconsin blog main
wisconsin top stories
a2 biotherapeutics
aduro biotech
advaxis
agency
aimmune therapeutics
akili interactive labs
alder biopharmaceuticals
alexander hardy
alicia hager
What
bio
2
×
crispr
2
×
roundup
alliance
big
bosley's
bosley’s
bridge
bristol
bucks
buy
calls
cas
ceo
changing
color
crime
days
departure
editas
exit
growing
guiding
hours
katrine
kudos
leaves
medicine
moves
myers’s
notifying
october
personnel
phone
rnai
rouse
scientists
shorter
slumber
surprising
Language
unset
Current search:
crispr
×
crispr-cas9
×
bio
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
